Literature DB >> 20507778

Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008.

Eduardo Hernández-Garduño, R Kevin Elwood.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20507778      PMCID: PMC3086241          DOI: 10.3201/eid1606.100228

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Lai et al. () reported an increase in the number of nontuberculous mycobacteria (NTM) isolates and patients with pulmonary NTM diseases after implementation of the BACTEC system (Becton Dickinson, Sparks, MD, USA) late in 2001. These authors also reported that the increase was mainly in persons infected with Mycobacterium avium complex (MAC) and M. abscessus. They stated that diseases caused by NTM were defined according to current diagnosis criteria published in 2007 (). This finding suggests that Lai et al. were able to review the clinical and radiologic information for all patients. We wonder whether they were also able to identify and exclude people with NTM colonization, i.e., persons with positive cultures for NTM who did not meet the American Thoracic Society disease criteria. It would have been interesting to know the trend in colonized persons. In a previous study from British Columbia (), we found an increase in the number of NTM isolates mostly in persons with MAC colonization. This finding coincided with implementation of a new laboratory technique in 2000, which suggested that the new technology is more sensitive in detecting MAC. In contrast with the findings of Lai et al., our study from British Columbia showed that the incidence in patients treated for NTM pulmonary disease (the group used as a surrogate of NTM disease) has been decreasing over time, which is reassuring. In Response: We thank Hernández-Garduño and Elwood for drawing attention to the issue of nontuberculous mycobacteria (NTM) colonization (), which was not described in our study (). Among 4,786 patients with NTM isolates treated at our hospital during 2000–2008, colonization was found in 76.9% (3,681), and only 23.1% (1,105) had NTM diseases according to the criteria of the American Thoracic Society and Infectious Diseases Society of America (). Annual proportions of NTM isolates causing colonizations ranged from 29.2% in 2001 to 19.8% in 2007. During the study period, annual incidences of NTM colonization and disease increased from 6.6/100,000 inpatients and 2.7/100,000 outpatients in 2000 to 34.5/100,000 inpatients and 10.2/100,000 outpatients in 2008. Mycobacterium avium complex (MAC) was the most prevalent species, colonizing 1,282 (34.8%) of 3,681 patients. Annual proportions of MAC isolates causing colonization ranged from 20.0% in 2000 to 12.6% in 2006. Annual incidence of MAC colonization increased from 1.9/100,000 inpatients in 2000 to 12.3/100,000 inpatients in 2008; incidence of MAC disease also increased from 0.5/100,000 inpatients in 2000 to 2.1/100,000 inpatients in 2008. M. abscessus, the second most common species in our study (), caused colonization and disease in 669 and 155 patients, respectively. Annual incidence of M. abscessus colonization and infection also increased from 1.49/100,000 inpatients and 0.3/100,000 outpatients in 2000 to 7.0/100,000 inpatients and 1.9/100,000 outpatients in 2008. Our study and a previous study in British Columbia () suggest that improvement in diagnostic methods would detect increased incidence of NTM, especially of MAC; most isolates identified in these studies were associated with colonization. We also demonstrated a gradual increase in the incidence of all NTM, MAC, and M. abscessus over time in Taiwan, which may be attributable to increasing vigilance and awareness of these bacteria as human pathogens and the increased population of immunocompromised patients. Thus, clinicians should consider diagnosing NTM diseases with sensitive and advanced laboratory methods because of the increasing population of patients at risk.
  3 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008.

Authors:  Chih Cheng Lai; Che Kim Tan; Chien Hong Chou; Hsiao Leng Hsu; Chun Hsing Liao; Yu Tsung Huang; Pan Chyr Yang; Kwen Tay Luh; Po Ren Hsueh
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

3.  The incidence of pulmonary non-tuberculous mycobacteria in British Columbia, Canada.

Authors:  E Hernández-Garduño; M Rodrigues; R K Elwood
Journal:  Int J Tuberc Lung Dis       Date:  2009-09       Impact factor: 2.373

  3 in total
  4 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

2.  In vitro drug susceptibility of 40 international reference rapidly growing mycobacteria to 20 antimicrobial agents.

Authors:  Hui Pang; Guilian Li; Li Wan; Yi Jiang; Haican Liu; Xiuqin Zhao; Zhongfu Zhao; Kanglin Wan
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Design, synthesis and evaluation of indole-2-carboxamides with pan anti-mycobacterial activity.

Authors:  Nicholas D Franz; Juan Manuel Belardinelli; Michael A Kaminski; Louis C Dunn; Vinicius Calado Nogueira de Moura; Michael A Blaha; Dan D Truong; Wei Li; Mary Jackson; E Jeffrey North
Journal:  Bioorg Med Chem       Date:  2017-05-08       Impact factor: 3.641

4.  Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013-2016.

Authors:  Yaoju Tan; Biyi Su; Wei Shu; Xingshan Cai; Shaojia Kuang; Haobin Kuang; Jianxiong Liu; Yu Pang
Journal:  BMC Pulm Med       Date:  2018-11-09       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.